title: Inhibition of the signal transduction through the AtoSC system by histidine kinase inhibitors in Escherichia coli.
abstract: AtoSC two-component system participates in many indispensable processes of Escherichia coli. We report here that the AtoSC signal transduction is inhibited by established histidine kinase inhibitors. Closantel, RWJ-49815 and TNP-ATP belonging to different chemical classes of inhibitors, abrogated the in vitro AtoS kinase autophosphorylation. However, when AtoS was embedded in the membrane fractions, higher inhibitor concentrations were required for total inhibition. When AtoS interacted with AtoC forming complex, the intrinsic histidine kinase was protected by the response regulator, requiring increased inhibitors concentrations for partially AtoS autophosphorylation reduction. The inhibitors exerted an additional function on AtoSC, blocking the phosphotransfer from AtoS to AtoC, without however, affecting AtoC~P dephosphorylation. Their in vivo consequences through the AtoSC inhibition were elucidated on atoDAEB operon expression, which was inhibited only in AtoSC-expressing bacteria where AtoSC was induced by acetoacetate or spermidine. The inhibitor effects were extended on the AtoSC regulatory role on cPHB [complexed poly-(R)-3-hydroxybutyrate] biosynthesis. cPHB was decreased upon the blockers only in acetoacetate-induced AtoSC-expressing cells. Increased ATP amounts during bacterial growth reversed the inhibitory TNP-ATP-mediated effect on cPHB. The alteration of pivotal E. coli processes as an outcome of AtoSC inhibition, establish this system as a target of two-component systems inhibitors.
authors: Laboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, GR-54124, Greece. evatheod@physics.auth.gr
authors: Evaggelos C
authors: EC
authors: Theodorou
authors: Marina C
authors: MC
authors: Theodorou
authors: Dimitrios A
authors: DA
authors: Kyriakidis
mesh_terms: D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology / Q000254:growth & development; D029968:Escherichia coli Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006146:Guanidines / Q000494:pharmacology; D000071677:Histidine Kinase; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011494:Protein Kinases / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D014320:Triphenylmethyl Compounds / Q000494:pharmacology
chemical_list: C505587:AtoC protein, E coli; D004268:DNA-Binding Proteins; D029968:Escherichia coli Proteins; D006146:Guanidines; D047428:Protein Kinase Inhibitors; C112247:RWJ 49815; D014320:Triphenylmethyl Compounds; D011494:Protein Kinases; D000071677:Histidine Kinase; C505586:AtoS protein, E coli